Why the study?
No studies had investigated the ability of the serum albumin to creatinine ratio to predict long-term mortality in patients experiencing STEMI.
Does the serum albumin to creatinine ratio (sACR) predict long-term all-cause mortality in patients with STEMI?
Does the serum albumin to creatinine ratio (sACR) predict long-term all-cause mortality in patients with STEMI?
A lower serum albumin to creatinine ratio (sACR) at admission is an independent predictor of long-term all-cause mortality in STEMI patients undergoing primary PCI.
sACR may aid long-term STEMI mortality prediction; leaves open its incremental value pending prospective validation.
No takes yet. Share an insight, caveat, or question.
Artaç et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: